Ophthotech Will Take Biogen/PDL Drug Volociximab Into The Clinic For AMD
This article was originally published in The Pink Sheet Daily
Executive Summary
Alpha 5 beta 1 integrin antagonist will move into the clinic “shortly,” CEO Patel tells “The Pink Sheet” DAILY.